SARS-CoV-2 seroprevalence and seroconversion in Finnish households with school-aged children between June 2020 and April 2022

dc.contributor.authorAhti, Jaakko
dc.contributor.authorOllila, Helena
dc.contributor.authorToivonen, Laura
dc.contributor.authorSalo-Tuominen, Krista
dc.contributor.authorIvaska, Lauri
dc.contributor.authorJulkunen, Ilkka
dc.contributor.authorPeltola, Ville
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=biostatistiikka|en=Biostatistics|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organizationfi=lastentautioppi|en=Paediatrics and Adolescent Medicine|
dc.contributor.organization-code1.2.246.10.2458963.20.40612039509
dc.contributor.organization-code1.2.246.10.2458963.20.89365200099
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id522859583
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/522859583
dc.date.accessioned2026-05-06T20:10:41Z
dc.description.abstract<p>Background<br></p><p>SARS-CoV-2 spreads efficiently in households with children. Here, we aimed to examine whether serological methods, in addition to PCR, can improve understanding of SARS-CoV-2 transmission within households.<br></p><p>Methods<br></p><p>Within the prospective birth-cohort study called the STEPS Study, 175 households with 376 children and 324 adults were prospectively followed for acute respiratory infections from June 2020 to April 2022. SARS-CoV-2 was tested by PCR and antigen tests. IgG antibodies against SARS-CoV-2 nucleoprotein (N) and spike (S) proteins were determined at recruitment and at two later timepoints to assess seroprevalence, and five weeks after a PCR-positive infection in the household to assess seroconversion. Secondary attack rates (SARs) based on seroconversion or PCR-positivity were calculated and compared among index and secondary cases.<br></p><p>Results<br></p><p>SARS-CoV-2 anti-N-IgG seroprevalence showed a minor increase from 0.5% at recruitment, starting in June 2020, to1.9% at the last serum collection. SARS-CoV-2 RNA was detected by PCR in altogether 334 (48%) participants. The SAR for the adult index cases was higher than the SAR for the child index cases (77% vs 48%; p = 0.0027). The SARs were similar for unvaccinated (0–1 vaccinations) and vaccinated (2–3 vaccinations) index cases (53% and 63%, respectively; p = 0.28), but the SAR for unvaccinated secondary cases was higher compared to the SAR for vaccinated secondary cases (83% vs 52%; p = 0.0067).<br></p><p>Conclusion<br></p><p>In this study, adults spread SARS-CoV-2 in households more efficiently than children. While the index case vaccination status showed no difference, unvaccinated household members were more prone to SARS-CoV-2 infection than vaccinated individuals.<br></p><p>Key points<br></p><p>A cohort of households with children was prospectively studied for SARS-CoV-2 transmission through repeated PCR, and serology was obtained 5 weeks post-infection. Adults transmitted the virus more effectively than children, and unvaccinated participants were more susceptible than vaccinated participants.<br></p><p>Keywords: children, COVID-19, household transmission, SARS-CoV-2, secondary attack rate, seroconversion, serology<br></p>
dc.embargo.lift2027-03-30
dc.identifier.eissn2374-4243
dc.identifier.jour-issn2374-4235
dc.identifier.urihttps://www.utupub.fi/handle/11111/60367
dc.identifier.urlhttps://doi.org/10.1080/23744235.2026.2648678
dc.identifier.urnURN:NBN:fi-fe2026042332789
dc.language.isoen
dc.okm.affiliatedauthorAhti, Jaakko
dc.okm.affiliatedauthorOllila, Helena
dc.okm.affiliatedauthorToivonen, Laura
dc.okm.affiliatedauthorSalo-Tuominen, Krista
dc.okm.affiliatedauthorIvaska, Lauri
dc.okm.affiliatedauthorJulkunen, Ilkka
dc.okm.affiliatedauthorPeltola, Ville
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherInforma Healthcare
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1080/23744235.2026.2648678
dc.relation.ispartofjournalInfectious Diseases
dc.titleSARS-CoV-2 seroprevalence and seroconversion in Finnish households with school-aged children between June 2020 and April 2022
dc.year.issued2026

Tiedostot